doi: 10.3389/fnut.2025.1686777 Received 15 August 2025 Revised 15 November 2025 Accepted 28 November 2025 Published 12 January 2026 Volume 12 - 2025 Edited by Andrea Orellana-Manzano, Escuela Superior Politcnica del Litoral (ESPOL), Ecuador Reviewed by Paulina Cerda Opazo, Autonomous University of Chile, Chile Aliakbar Fazaeli, Ardabil University of Medical Sciences, Iran Updates Copyright 2026 Garutti, de Scordilli, Alberti, Mazzeo, Michelotti, Fagioli, Del Conte, Casirati, Caccialanza, Bartolini and Puglisi
Its worth noting that one potential drawback of this copper peptide serum may lie in how acidic it is or, rather, isnt
Cancer Lett (2019) 454:14657
Ethics declarations Conflict of interest Not applicable
Enter BPC-157: The Body Protection Compound How do we fix the wall
One patient with medullary breast cancer metastatic to lung and lymph nodes underwent extensive pretreatment (8 previous systemic treatment options) was reported to have a confirmed partial response (PR) with a duration of 65 days when treated with 45 mg/kg 2-DG every other week (298)